| |
|
|
|
|
|
|
|
|
1. |
Record Nr. |
UNINA9910807493803321 |
|
|
Autore |
Ghosh Shubha |
|
|
Titolo |
Identity, invention, and the culture of personalized medicine patenting / / Shubha Ghosh, University of Wisconsin-Madison School of Law [[electronic resource]] |
|
|
|
|
|
|
|
Pubbl/distr/stampa |
|
|
Cambridge : , : Cambridge University Press, , 2012 |
|
|
|
|
|
|
|
ISBN |
|
1-139-88841-2 |
1-139-56424-2 |
1-139-54943-X |
1-283-61053-1 |
1-139-55068-3 |
9786613922984 |
0-511-99763-9 |
1-139-55564-2 |
1-139-55439-5 |
1-139-55193-0 |
|
|
|
|
|
|
|
|
Descrizione fisica |
|
1 online resource (xiii, 216 pages) : digital, PDF file(s) |
|
|
|
|
|
|
Classificazione |
|
|
|
|
|
|
Disciplina |
|
|
|
|
|
|
Soggetti |
|
Medical laws and legislation |
Patent laws and legislation |
Biotechnology |
Biotechnology - Law and legislation |
Pharmacogenetics |
Personality (Law) |
|
|
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Note generali |
|
Title from publisher's bibliographic system (viewed on 05 Oct 2015). |
|
|
|
|
|
|
Nota di bibliografia |
|
Includes bibliographical references and index. |
|
|
|
|
|
|
Nota di contenuto |
|
Persons and patents -- Start-ups, up-starts, and markets for personalized medicine -- The case of race-specific patents -- Normative construction of identity -- Persons, patents, and policy -- A business, a litigant, a metaphor : the future of personalized medicine patents. |
|
|
|
|
|
|
|
|
Sommario/riassunto |
|
What are the normative implications of patenting in the area of |
|
|
|
|
|
|
|
|
|
|
personalized medicine? As patents on genes and medical diagnoses have increased over the past decade, this question lies at the intersection of intellectual property theory, identity politics, biomedical ethics and constitutional law. These patents are part of the personalized medicine industry, which develops medical treatments tailored to individuals based on race and other characteristics. This book provides an overview of developments in personalized medicine patenting and suggests policies to best regulate such patents. |
|
|
|
|
|
| |